Intrinsiqq
Orchestra BioMed Holdings, Inc. logo

Orchestra BioMed Holdings, Inc. Dividend Analysis

OBIO

⊜ Compare
Dividend0
No active dividend

This company discontinued its dividend after 2022.

Based on TTM and annual data · Not a buy/sell signal

This company does not pay dividends

Last dividend was paid in 2022. The company has not paid dividends in the last 3 years.

Does Orchestra BioMed Holdings (OBIO) pay a dividend?

Orchestra BioMed Holdings (OBIO) stopped paying a dividend after 2022 and pays nothing today. Free cash flow is currently negative, so there is no surplus to distribute. All figures are computed from company filings; this is analysis, not investment advice.

Frequently asked

Does Orchestra BioMed Holdings (OBIO) pay a dividend?+

No. Orchestra BioMed Holdings (OBIO) does not currently pay a dividend. The last payment in our data was in 2022, and nothing has been paid since.

How does Orchestra BioMed Holdings return cash to shareholders?+

It largely does not. Orchestra BioMed Holdings pays no dividend and we do not see a meaningful reduction in share count over the last twelve months, so cash is being retained in the business or spent on growth rather than returned. That is common for companies reinvesting heavily, and it means your return depends entirely on the share price.

Could Orchestra BioMed Holdings afford to pay a dividend?+

Not currently. Orchestra BioMed Holdings's free cash flow is negative at -$59 million, meaning the business consumed cash over the period rather than generating it. A company funding a dividend from cash it is not producing would be paying shareholders out of its balance sheet or borrowings, which is not sustainable.

Which healthcare companies do pay dividends?+

Our Healthcare sector page ranks the companies we cover by dividend score, which combines payout safety, free cash flow coverage and growth record. If income is what you are after, start there rather than with Orchestra BioMed Holdings.

SourceDividend analysis computed from the 10-Q filed 6 Aug 2026, covering the period ending 30 Jun 2026, as reported to the SEC. Data last refreshed 11 Aug 2026. How this is calculated.

Fiscal year ends Dec. Earnings payout = dividends / net income. FCF payout = dividends / FCF. Yield = TTM DPS / price.

Peers

Surgical & Medical Instruments & Apparatus · Pick stocks to compare with OBIO

CompareIntrinsic value
PREMPremier Air Charter Holdings Inc.
$0.02-20.00%15
SSKNStrata Skin Sciences Inc.
$0.00+100.00%0
IDXGInterpace Biosciences Inc.
$5.72+5.09%82
DYNTQDynatronics Corp
$0.00+0.00%29
RVPRetractable Technologies Inc.
$0.57+1.79%20
CTSOCytosorbents Corporation
$4.56+0.44%15
UTMDUtah Medical Products Inc.
$72.42+3.43%40
SRTSSensus Healthcare Inc.
$3.25-1.07%18

Held by ETFs

OBIO is in 6 US ETFs. The largest of them, with OBIO's weight in each:

Spot a number that looks wrong? Check it in OBIO's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing OBIO

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.